Lindahl has assisted the leading bioscience company Avantor
Lindahl has assisted Avantor in concluding a project- and lease agreement to establish a new 500 sqm distribution centre for the Nordic region.
Avantor, one of the 500 largest companies in the USA – Fortune 500 companies – and a leading actor within bioscience instruments, is a global supplier of critical products and services to customers within bioscience and advanced technology. Its products are used in over 300,000 facilities in 180 countries.
On 16 May 2024, Avantor's newly built high-tech distribution centre was opened in Örebro to supply the Nordic market with its products. Advokatfirman Lindahl, represented by Dennis Dicksen, assisted Avantor in drawing up the project- and lease agreement.
Do you want to know more? Contact:
Dennis Dicksen
PartnerCarousel items
-
Cases and transactions
12/11/2025
Lindahl advises Medivir on rights issue of approximately SEK 151 million
Lindahl has acted as legal adviser to Medivir AB (publ) in connection with the company's fully guaranteed rights issue of approximately SEK 151 million to finance a clinical trial of the drug candidate Fostrox.
-
Knowledge
12/9/2025
Avoid costly disputes – regulate jurisdiction clauses in your international agreements
Lindahl has extensive experience in handling cross-border disputes and can help you create clear, secure contracts. Contact our dispute resolution specialists for guidance on international jurisdiction and applicable law.
-
News articles
12/4/2025
Lindahl ranked in Chambers FinTech Guide 2026
Lindahl has been ranked in the Chambers FinTech Guide 2026: Sweden. Both the firm and partner Anna Wahlbom are ranked in Band 4.
-
Portraits
11/7/2025
Capital markets and public M&A at Lindahl: Expertise, working environment and range
Read about how Monica Lagercrantz and Lindahl's experts in capital markets and public M&A support companies with stock exchange listings, new share issues and ongoing advice – with expertise, range and a working environment that makes a difference.
-
Read more news and insights?